Crispr Therapeutics Ag (NQ: CRSP )

112.69 USD +4.85 (+4.50%)

Streaming Delayed Price Updated: 10:21 AM EDT, May 7, 2021 Add to My Watchlist

Price and Volume

Volume	426,364
Open	110.30
Bid (Size)	112.58 (1)
Ask (Size)	112.80 (10)
Prev. Close	107.84
Today's Range	109.71 - 114.32
52wk Range	51.63 - 220.20
Shares Outstanding	75,768,936
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer

May 06, 2021

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

April 29, 2021

Performance

YTD	-28.68%	-28.68%
1 Month	-7.35%	-7.35%
3 Month	-32.84%	-32.84%
6 Month	+9.05%	+9.05%
1 Year	+115.34%	+115.34%

More News

CRISPR Therapeutics Announces Trials in Progress Poster Presentation at the 2021 American Society of Clinical Oncology Annual Meeting

April 28, 2021

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results

April 27, 2021

Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia

April 26, 2021

Interesting CRSP Put And Call Options For June 25th

May 06, 2021

With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market

Today 6:40 EDT

This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon

May 04, 2021

Forget Penny Stocks: Buy These 2 Stocks Instead

May 01, 2021

Will Vertex's Sickle Cell Gambit Sink bluebird bio's Stock?

May 01, 2021

Have $1,000 to Invest? Buy These 2 Growth Stocks Right Now

April 30, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.